These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31671234)

  • 1. In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance.
    Santilli F; Zaccardi F; Liani R; Petrucci G; Simeone P; Pitocco D; Tripaldi R; Rizzi A; Formoso G; Pontecorvi A; Angelucci E; Pagliaccia F; Golato M; De Leva F; Vitacolonna E; Rocca B; Consoli A; Patrono C
    Diabetes Metab Res Rev; 2020 Feb; 36(2):e3232. PubMed ID: 31671234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.
    Davì G; Gresele P; Violi F; Basili S; Catalano M; Giammarresi C; Volpato R; Nenci GG; Ciabattoni G; Patrono C
    Circulation; 1997 Jul; 96(1):69-75. PubMed ID: 9236419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.
    Davì G; Ciabattoni G; Consoli A; Mezzetti A; Falco A; Santarone S; Pennese E; Vitacolonna E; Bucciarelli T; Costantini F; Capani F; Patrono C
    Circulation; 1999 Jan; 99(2):224-9. PubMed ID: 9892587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane biosynthesis and future events in diabetes: the ASCEND trial.
    Petrucci G; Buck GA; Rocca B; Parish S; Baigent C; Hatem D; Mafham M; Habib A; Bowman L; Armitage J; Patrono C
    Eur Heart J; 2024 Apr; 45(15):1355-1367. PubMed ID: 38385506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of urinary 11-dehydro-thromboxane B
    Simeone P; Boccatonda A; Liani R; Santilli F
    Ageing Res Rev; 2018 Dec; 48():51-78. PubMed ID: 30273676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal cation exchange in insulin-resistant patients with essential hypertension.
    Taylor DR; Wing JR; Sonnekus MI; Toman M; Milne FJ
    Cardiovasc J Afr; 2008; 19(2):67-71. PubMed ID: 18516349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes.
    Zaccardi F; Rizzi A; Petrucci G; Ciaffardini F; Tanese L; Pagliaccia F; Cavalca V; Ciminello A; Habib A; Squellerio I; Rizzo P; Tremoli E; Rocca B; Pitocco D; Patrono C
    Diabetes; 2016 Feb; 65(2):503-9. PubMed ID: 26470782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.
    Motala AA; Omar MA; Gouws E
    Diabetes Care; 1997 Jul; 20(7):1101-7. PubMed ID: 9203444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of sleep time with diabetes mellitus and impaired glucose tolerance.
    Gottlieb DJ; Punjabi NM; Newman AB; Resnick HE; Redline S; Baldwin CM; Nieto FJ
    Arch Intern Med; 2005 Apr; 165(8):863-7. PubMed ID: 15851636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Metabolomics to Identify and Stratify Patients With Impaired Glucose Tolerance.
    Wildberg C; Masuch A; Budde K; Kastenmüller G; Artati A; Rathmann W; Adamski J; Kocher T; Völzke H; Nauck M; Friedrich N; Pietzner M
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6357-6370. PubMed ID: 31390012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing incidence of abnormal glucose tolerance in women with prior abnormal glucose tolerance during pregnancy: DIAGEST 2 study.
    Vambergue A; Dognin C; Boulogne A; Réjou MC; Biausque S; Fontaine P
    Diabet Med; 2008 Jan; 25(1):58-64. PubMed ID: 18028442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abnormal glucose tolerance and long-term prognosis in patients with acute myocardial infarction].
    David LA; Grosu AA
    Kardiologiia; 2013; 53(9):15-20. PubMed ID: 24090381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic defects in persistent impaired glucose tolerance are related to the family history of non-insulin-dependent diabetes mellitus.
    Niskanen L; Sarlund H; Laakso M
    Metabolism; 1995 Aug; 44(8):1099-104. PubMed ID: 7637652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
    Henninger J; Hammarstedt A; Rawshani A; Eliasson B
    BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type II Diabetes Mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors.
    Al-Habori M; Al-Mamari M; Al-Meeri A
    Diabetes Res Clin Pract; 2004 Sep; 65(3):275-81. PubMed ID: 15331208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward?
    Wong MS; Gu K; Heng D; Chew SK; Chew LS; Tai ES
    Diabetes Care; 2003 Nov; 26(11):3024-30. PubMed ID: 14578234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of years since menopause on the development of impaired glucose tolerance.
    Wu SI; Chou P; Tsai ST
    J Clin Epidemiol; 2001 Feb; 54(2):117-20. PubMed ID: 11166525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.